Endometrial Cancer Stage I clinical trials

Explore recruiting endometrial cancer stage i clinical trials.

Recruiting endometrial cancer stage i studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Endometrial Cancer Stage I trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II, Single-Arm Study of Giredestrant in Patients with Grade 1 Endometrial Cancer

Poland, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

SENtinel lymph node mapping with GAllium-68-tilmanocept PET/CT in high/high- intermediate risk endometrial cancer: a proof-of-concept study

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Endometrial Cancer Stage I trials by city

Endometrial Cancer Stage I clinical trials

Recruiting endometrial cancer stage i studies right now

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer

CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

A Study of a Weight Loss Intervention in People With Endometrial Cancer

BP1001-A in Patients With Advanced or Recurrent Solid Tumors

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Sentinel Node Biopsy in Endometrial Cancer

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)

Also recruiting in Europe

A Phase II, Single-Arm Study of Giredestrant in Patients with Grade 1 Endometrial Cancer

SENtinel lymph node mapping with GAllium-68-tilmanocept PET/CT in high/high- intermediate risk endometrial cancer: a proof-of-concept study

Endometrial Cancer Stage I trials by city

Other conditions